Singapore, Singapore

Motoichi Kurisawa

This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Biomedical Applications. Top assignee: Agency for Science, Technology and Research. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoichi Kurisawa. Retrieved from https://idiyas.com/inventor/motoichi-kurisawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 28.6


 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nanocomplex
Polymer-Flavonoid Conjugates
Hydrogels
Anti-Cancer Delivery
Cell-Adhesive Hydrogels
Bioactive Agents
Phase Separated Composite
Particulate Formulations
Crosslinked Hydrogels
Hyaluronic Acid
Enzymatically Crosslinked
Micellar Nanocomplex
21 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Motoichi Kurisawa in Biomedical Engineering

Introduction

Motoichi Kurisawa is a distinguished inventor based in Singapore, known for his significant contributions to the field of biomedical engineering. With a remarkable portfolio of 21 patents, Kurisawa has made substantial advancements, particularly in the development of novel nanocomplexes and polymer-flavonoid conjugates aimed at improving medical treatments.

Latest Patents

Among his latest innovations is a patent for a nanocomplex that features a core-shell structure. This groundbreaking nanocomplex includes a shell comprised of functionalized hyaluronic acid, while its core encapsulates a metal-containing compound within a flavonoid, specifically epigallocatechin gallate (EGCG). The methodology for the formation of this nanocomplex, alongside its pharmaceutical applications and potential for cancer treatment, underscores its significance in modern medicine.

Another important patent involves the creation of polymer-flavonoid conjugates and hydrogels tailored for biomedical applications. These conjugates, linked via thiol connections, can be synthesized with high yields while simplifying the purification processes. The generated hydrogels, which can be utilized as viscosupplements, anti-adhesion films, or dermal fillers, enhance the stability of the flavonoids and represent a promising direction for future biomedical solutions.

Career Highlights

Kurisawa is affiliated with the Agency for Science, Technology and Research, where he utilizes his expertise to spearhead innovative research projects. His work combines advanced materials science with clinical applications, aiming to bridge the gap between laboratory discoveries and practical medical treatments.

Collaborations

Motoichi has collaborated with colleagues such as Joo Eun Chung and Fan Lee, fostering a dynamic research environment that drives innovation. These collaborations are essential in pushing the boundaries of current biomedical technology and expanding the potential applications of his findings.

Conclusion

With his extensive patent portfolio and groundbreaking research, Motoichi Kurisawa stands out as a leading figure in the field of biomedical engineering in Singapore. His innovative work continues to pave the way for new therapeutic possibilities, making significant contributions to healthcare advancements. As the medical field evolves, Kurisawa’s inventions will undoubtedly play a vital role in shaping future treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…